These differences might reflect different roles of CYP1A1 during the initial transformation of cells, which commonly requires biotransformation activities, as compared to later stages of tumor promotion and progression, which are considered to be influenced by infiltrating immune cells. The gene discussed is CYP1A1; the disease is neoplasm.